0001179110-22-000397.txt : 20220111 0001179110-22-000397.hdr.sgml : 20220111 20220111161807 ACCESSION NUMBER: 0001179110-22-000397 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220107 FILED AS OF DATE: 20220111 DATE AS OF CHANGE: 20220111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klein Matthew B. CENTRAL INDEX KEY: 0001808968 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 22524101 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 edgar.xml FORM 4 - X0306 4 2022-01-07 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001808968 Klein Matthew B. C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 Chief Operating Officer Common Stock 2022-01-07 4 S 0 775 38.525 D 16461 D Common Stock 2022-01-07 4 A 0 21000 0 A 37461 D Common Stock 2022-01-07 4 A 0 20000 0 A 57461 D Stock Option (Right to Buy) 38.10 2022-01-07 4 A 0 52500 0 A 2032-01-06 Common Stock 52500 52500 D Stock Option (Right to Buy) 38.10 2022-01-07 4 A 0 50000 0 A 2032-01-06 Common Stock 50000 50000 D Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs. Includes 203 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 224 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021. Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023. Restricted stock units granted on January 7, 2022 that vest in two equal installments over two years, commencing on January 7, 2023. This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023. This option was granted on January 7, 2022 and vests in two equal installments over two years, commencing on January 7, 2023. /s/ Avraham S. Adler, attorney-in-fact 2022-01-11